<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03041805</url>
  </required_header>
  <id_info>
    <org_study_id>CAPSIVS</org_study_id>
    <nct_id>NCT03041805</nct_id>
  </id_info>
  <brief_title>Caprini Score in Venous Surgery: a Prospective Cohort Study</brief_title>
  <acronym>CAPSIVS</acronym>
  <official_title>A Prospective Cohort Register Study for Validation of Caprini Score in Patients Undergoing Varicose Vein Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pirogov Russian National Research Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pirogov Russian National Research Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to make a validation of Caprini score in patients undergoing varicose
      veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT,
      radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify
      patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit
      from prophylactic anticoagulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective cohort study based on the platform of Ongoing Registry of Treatment of Chronic
      Venous Diseases (NCT03035747). The study will enrol adult patients undergoing any kind of
      varicose veins surgery with and without any prophylaxis. The patients should be examined for
      venous thromboembolic complications during 2-4 weeks after the procedure with mandatory
      duplex ultrasound.

      The study will provide following information:

        -  the rate of asymptomatic DVT after varicose veins surgery

        -  the rate of symptomatic VTE after varicose veins surgery

        -  the rate of thermal-induced thrombosis (EHIT) after endovenous thermal ablation

        -  the ability of Caprini scores to predict VTE after varicose veins surgery

        -  identification of patients with high risk of VTE who will benefit from prophylaxis,
           especially with anticoagulation
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>any episode of VTE</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
    <description>symptomatic or asymptomatic, confirmed by instrumental diagnostics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>symptomatic deep vein thrombosis</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
    <description>symptomatic deep vein thrombosis confirmed by duplex ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>symptomatic pulmonary embolism</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
    <description>symptomatic pulmonary embolism confirmed by perfusion isotope scanning or CT pulmonary angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>asymtomatic deep vein thrombosis</measure>
    <time_frame>2-4 weeks after procedure</time_frame>
    <description>asymptomatic DVT revealed by duplex ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endovenous thermal-induced thrombosis</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
    <description>EHIT revealed by duplex ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major bleeding</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
    <description>Fatal bleeding, and/or symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intraarticular or pericardial, or intramuscular with compartment syndrome, and/or bleeding causing a fall in haemoglobin level of 20 g/L or more, or leading to transfusion of two or more units of whole blood or red cells.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinicaly relevant bleeding</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
    <description>any non-major bleeding need for treatment or intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death for any reason</measure>
    <time_frame>0-4 weeks after procedure</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Venous Thromboembolism</condition>
  <condition>Varicose Veins</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EVLT</intervention_name>
    <description>Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RFA</intervention_name>
    <description>Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>USFS</intervention_name>
    <description>Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HL/stripping</intervention_name>
    <description>High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Miniphlebectomy</intervention_name>
    <description>Miniphlebectomy of any varicose veins under local, regional or general anaesthesia</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sclerotherapy</intervention_name>
    <description>Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GCS</intervention_name>
    <description>Graduated compression stockings may be used after procedure by the decision of the doctor</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LMWH</intervention_name>
    <description>Low-molecular-weight heparin may be used after procedure by the decision of the doctor</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient with varicose veins that undergoing any kind of varicose vein surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age over 18 years

          -  any kind of varicose vein surgery

          -  follow up for 4 weeks after the procedure

          -  examination for VTE at 2-4 weeks after the procedure, including duplex ultrasound

        Exclusion Criteria:

        - lost for follow-up during 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirill Lobastov, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pirogov Russian National Research Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kirill Lobastov, PhD</last_name>
    <phone>+7-985-211-63-31</phone>
    <email>lobastov_kv@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pirogov Russian National Research Medical University</name>
      <address>
        <city>Moscow</city>
        <zip>117997</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirill Lobastov, PhD</last_name>
      <phone>+7-985-211-63-31</phone>
      <email>lobastov_kv@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2017</study_first_submitted>
  <study_first_submitted_qc>February 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2017</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pirogov Russian National Research Medical University</investigator_affiliation>
    <investigator_full_name>Kirill Lobastov</investigator_full_name>
    <investigator_title>Associated Professor</investigator_title>
  </responsible_party>
  <keyword>venous thromboembolism</keyword>
  <keyword>deep vein thrombosis</keyword>
  <keyword>pulmonary embolism</keyword>
  <keyword>varicose veins</keyword>
  <keyword>surgery</keyword>
  <keyword>endovenous laser treatment</keyword>
  <keyword>radiofrequency ablation</keyword>
  <keyword>ultrasound-guided foam sclerotherapy</keyword>
  <keyword>register</keyword>
  <keyword>anticoagulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

